FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andreas Schwarting

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Manfred Relle; Nadine Schommers; Hannes Cash; Peter R Galle; Kurt Reifenberg; Andreas Schwarting
PR3 antibodies do not induce renal pathology in a novel PR3-humanized mouse model for Wegener's granulomatosis.
Manfred Relle; Andreas Schwarting
Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.
Manfred Relle; Peter R Galle; Thomas Thomaidis; Andreas Schwarting
Comparative aspects of murine proteinase 3.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andreas Schwarting (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Manfred Relle; Nadine Schommers; Hannes Cash; Peter R Galle; Kurt Reifenberg; Andreas Schwarting
PR3 antibodies do not induce renal pathology in a novel PR3-humanized mouse model for Wegener's granulomatosis.
Rheumatology international 2013;33(3):613-22.
2012: Manfred Relle; Andreas Schwarting
Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.
Clinical & developmental immunology 2012;2012():584374.
2011: Manfred Relle; Peter R Galle; Thomas Thomaidis; Andreas Schwarting
Comparative aspects of murine proteinase 3.
Rheumatology international 2011;31(8):1105-11.
2011: Julia Menke; Tillmann Bork; Birte Kutska; Katelyn T Byrne; Michaela Blanfeld; Manfred Relle; Vicki R Kelley; Andreas Schwarting
Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.
Kidney international 2011;79(4):452-63.
2010: Hannes Cash; Manfred Relle; Julia Menke; Christoph Brochhausen; Simon A Jones; Nicholas Topley; Peter R Galle; Andreas Schwarting
Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
The Journal of rheumatology 2010;37(1):60-70.
2009: Julia Menke; Whitney A Rabacal; Katelyn T Byrne; Yasunori Iwata; Melvin M Schwartz; E Richard Stanley; Andreas Schwarting; Vicki R Kelley
Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis.
Journal of the American Society of Nephrology : JASN 2009;20(12):2581-92.
2009: Thomas Thomaidis; Manfred Relle; Joerg Reinke; Michael Beck; Andreas Schwarting
[Effect of enzyme replacement therapy (ERT) on renal function of patients with Fabry's disease].
Medizinische Klinik (Munich, Germany : 1983) 2009;104(9):699-703.
2009: Julia Menke; Yasunori Iwata; Whitney A Rabacal; Ranu Basu; Yee-Guide Yeung; Benjamin D Humphreys; T Wada; Andreas Schwarting; E Richard Stanley; Vicki R Kelley
CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice.
The Journal of clinical investigation 2009;119(8):2330-42.
2009: Markus Bosmann; Andreas Schwarting
[Non-invasive monitoring of fluid balance].
Deutsche medizinische Wochenschrift (1946) 2009;134(9):421-4.
2009: Thomas Thomaidis; Manfred Relle; Mitra Golbas; Christoph Brochhausen; Peter R Galle; Michael Beck; Andreas Schwarting
Downregulation of alpha-galactosidase A upregulates CD77: functional impact for Fabry nephropathy.
Kidney international 2009;75(4):399-407.
2008: Martin Goetz; S Thomas; Axel Heimann; Peter M Delaney; C Schneider; M Relle; Andreas Schwarting; Peter R Galle; Oliver Kempski; Markus F Neurath; Steven Thomas
Dynamic in vivo imaging of microvasculature and perfusion by miniaturized confocal laser microscopy.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 2008;41(3):290-7.
2006: Catharina Whybra; Andreas Schwarting; Jörg Kriegsmann; Andreas Gal; Eugen Mengel; Christoph Kampmann; Frank Baehner; Ellen Schaefer; Michael Beck
IgA nephropathy in two adolescent sisters heterozygous for Fabry disease.
Pediatric nephrology (Berlin, Germany) 2006;21(9):1251-6.
2006: Andreas Schwarting; François Dehout; S Feriozzi; Michael Beck; Atul Mehta; Gere Sunder-Plassmann
Enzyme replacement therapy and renal function in 201 patients with Fabry disease.
Clinical nephrology 2006;66(2):77-84.
2006: Julia Kleinert; François Dehout; Andreas Schwarting; Abelardo García de Lorenzo; Roberta Ricci; Christoph Kampmann; Michael Beck; Uma Ramaswami; Ales Linhart; Andreas Gal; Gunnar Houge; Urs Widmer; Atul Mehta; Gere Sunder-Plassmann
Prevalence of uncontrolled hypertension in patients with Fabry disease.
American journal of hypertension 2006;19(8):782-7.
2006: Geraldine Zeller; Junichi Hirahashi; Andreas Schwarting; Arlene H Sharpe; Vicki R Kelley
Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus.
Journal of the American Society of Nephrology : JASN 2006;17(1):122-30.
2005: Andreas Schwarting; Kathrin Paul; Stefan Tschirner; Julia Menke; Torsten Hansen; Walburgis Brenner; Vicki R Kelley; Manfred Relle; Peter R Galle
Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
Journal of the American Society of Nephrology : JASN 2005;16(11):3264-72.
2005: Julia Kleinert; François Dehout; Andreas Schwarting; Abelardo García de Lorenzo; Roberta Ricci; Christoph Kampmann; Michael Beck; Uma Ramaswami; Ales Linhart; Andreas Gal; Gunnar Houge; Urs Widmer; Atul Mehta; Gere Sunder-Plassmann
Anemia is a new complication in Fabry disease: data from the Fabry Outcome Survey.
Kidney international 2005;67(5):1955-60.
2005: Andreas Schwarting; Elisabeth Märker-Hermann
[Renal manifestations of rheumatic diseases].
Zeitschrift für Rheumatologie 2005;64(1):18-25.
2005: Christian Walter; Andreas Schwarting; Torsten Hansen; Gernot Weibrich
[Heerfordt's syndrome -- a rare initial manifestation of sarcoidosis].
Mund-, Kiefer- und Gesichtschirurgie : MKG 2005;9(1):43-7.
2004: Jürgen Kuball; Matthias Theobald; Edite Antunes Ferreira; Georg Hess; Jürgen Burg; Giancarlo Maccagno; Ana P Barreiros; Stefan Lüth; Carl C Schimanski; Marcus Schuchmann; Andreas Schwarting; Markus F Neurath; Gerd Otto; Peter R Galle; Ansgar W Lohse
Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions.
Transplantation 2004;78(12):1774-9.
2004: Catharina Whybra; Christoph Kampmann; Frank Krummenauer; Markus Ries; Eugen Mengel; E Miebach; Frank Baehner; K Kim; Manal Bajbouj; Andreas Schwarting; Andreas Gal; Michael Beck
The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.
Clinical genetics 2004;65(4):299-307.
2003: François Dehout; Andreas Schwarting; Michael Beck; Atul Mehta; Roberta Ricci; Urs Widmer
Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data.
Acta paediatrica (Oslo, Norway : 1992). Supplement 2003;92(443):14-5; discussion 5.
2003: Manfred Relle; Werner-Johannes Mayet; Dennis Strand; Walburgis Brenner; Peter R Galle; Andreas Schwarting
Proteinase 3/myeloblastin as a growth factor in human kidney cells.
Journal of nephrology 2003;16(6):831-40.
2003: Jörg Kriegsmann; M Otto; Evelyn Wandel; Andreas Schwarting; J Faust; T Hansen; J Beck; Catharina Whybra; M Beck
[Fabry's disease, glomerulonephritis with crescentic and granulomatous interstitial nephritis. Case of one family].
Der Pathologe 2003;24(6):439-43.
2003: Geraldine Zeller; Evelyn Wandel; Andreas Schwarting
[Mitomycin-induced hemolytic-uremic syndrome].
Deutsche medizinische Wochenschrift (1946) 2003;128(25-26):1399-402.
2003: M Goetz; Peter R Galle; Andreas Schwarting
Non-fatal acute liver injury possibly related to high-dose ciprofloxacin.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003;22(5):294-6.
2002: Justus Faust; Julia Menke; Jörg Kriegsmann; Vicki R Kelley; Werner-Johannes Mayet; Peter R Galle; Andreas Schwarting
Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
Arthritis and rheumatism 2002;46(11):3083-95.
2002: Torsten Hansen; Holger Brockmann; Andreas Gaumann; Werner-Johannes Mayet; Andreas Schwarting; Peter R Galle; Jörg Kriegsmann
[Fulminant course of diffuse alveolar hemorrhage in systemic lupus erythematosus--a case report].
Zeitschrift für Rheumatologie 2002;61(2):175-9.
2002: Katja Hattar; Ulrich Grandel; Annette Bickenbach; Andreas Schwarting; Werner-Johannes Mayet; Juergen Bux; Sönke Jessen; Claus Fischer; Werner Seeger; Friedrich Grimminger; Ulf Sibelius
Interaction of antibodies to proteinase 3 (classic anti-neutrophil cytoplasmic antibody) with human renal tubular epithelial cells: impact on signaling events and inflammatory mediator generation.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(6):3057-64.
2002: Holger Brockmann; Andreas Schwarting; Jörg Kriegsmann; Peter Petrow; Andreas Gaumann; Klaus-Michael Müller; Peter Galle; Werner-Johannes Mayet
Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis.
Arthritis research 2002;4(3):220-5.
2001: W Mück; S Park; W Jäger; B Voith; Evelyn Wandel; Peter Galle; Andreas Schwarting
The pharmacokinetics of cerivastatin in patients on chronic hemodialysis.
International journal of clinical pharmacology and therapeutics 2001;39(5):192-8.
2001: T Wada; Andreas Schwarting; Mark S Chesnutt; David Wofsy; V Rubin Kelley
Nephritogenic cytokines and disease in MRL-Fas(lpr) kidneys are dependent on multiple T-cell subsets.
Kidney international 2001;59(2):565-78.
2000: Andreas Schwarting; D Hagen; M Odenthal; Holger Brockmann; Hans P Dienes; Evelyn Wandel; H J Rumpelt; K-H Meyer zum Büschenfelde; Peter R Galle; Werner-Johannes Mayet
Proteinase-3 mRNA expressed by glomerular epithelial cells correlates with crescent formation in Wegener's granulomatosis.
Kidney international 2000;57(6):2412-22.
2000: K Kinoshita; Gregory H Tesch; Andreas Schwarting; Ruth Maron; Arlene H Sharpe; Vicki R Kelley
Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(11):6046-56.
1999: Gregory H Tesch; S Maifert; Andreas Schwarting; Barrett J Rollins; Vicki R Kelley
Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice.
The Journal of experimental medicine 1999;190(12):1813-24.
1999: Andreas Schwarting; Gregory H Tesch; K Kinoshita; Ruth Maron; Howard L Weiner; Vicki R Kelley
IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(12):6884-91.
1999: Werner-Johannes Mayet; Andreas Schwarting; Ana P Barreiros; Joerg F Schlaak; Markus F Neurath
Anti-PR-3 antibodies induce endothelial IL-8 release.
European journal of clinical investigation 1999;29(11):973-9.
1999: T Wada; Andreas Schwarting; K Kinoshita; T Naito; RC Griffiths; Thomas M Coffman; Vicki R Kelley
Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice.
Kidney international 1999;55(3):841-51.
1999: Gregory H Tesch; Andreas Schwarting; K Kinoshita; H Y Lan; Barrett J Rollins; Vicki R Kelley
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis.
The Journal of clinical investigation 1999;103(1):73-80.
1998: Andreas Schwarting; T Wada; K Kinoshita; Gregory H Tesch; Vicki R Kelley
IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(1):494-503.
1998: Andreas Schwarting; K Moore; T Wada; Gregory H Tesch; H J Yoon; Vicki R Kelley
IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(8):4074-81.
1997: B M Wittig; Ulrich Treichel; Roman A Blaheta; Thomas Schreiter; Andreas Schwarting; Karl-Hermann Meyer zum Büschenfelde; Werner-Johannes Mayet
Soluble E-selectin enhances intercellular adhesion molecule-1 (ICAM-1) expression in human tumor cell lines.
Experimental cell research 1997;237(2):364-70.
1997: Werner-Johannes Mayet; Andreas Schwarting; Thomas Orth; Ulf Sibelius; Katja Hattar; Karl-Hermann Meyer zum Büschenfelde
Signal transduction pathways of membrane expression of proteinase 3 (PR-3) in human endothelial cells.
European journal of clinical investigation 1997;27(11):893-9.
1997: Andreas Schwarting; Joerg F Schlaak; Evelyn Wandel; Karl-Hermann Meyer zum Büschenfelde; Werner-Johannes Mayet
Human renal tubular epithelial cells as target cells for antibodies to proteinase 3 (c-ANCA).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(5):916-23.
1997: R Loew; Christoph Dueber; Andreas Schwarting; Manfred Thelen
Subcutaneous implantation metastasis of a cholangiocarcinoma of the bile duct after percutaneous transhepatic biliary drainage (PTBD).
European radiology 1997;7(2):259-61.
1996: G Teuber; Andreas Schwarting; P Mildenberger; G Schmidt-Brücken; R Moll; A Bornemann; Evelyn Wandel; Roland Wanitschke; K H Meyer zum Büschenfelde
[Invasive disseminated aspergillosis in combined immunosuppressive therapy in systemic lupus erythematosus].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(12):798-801.
1996: Werner-Johannes Mayet; Thomas Orth; Andreas Schwarting; K H Meyer zum Büschenfelde; Guido Gerken
[Significance of antineutrophil cytoplasmic antibodies (ANCA) in diagnosis and immunopathogenesis of chronic inflammatory liver diseases].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(6):384-8.
1996: Werner-Johannes Mayet; W Schmitt; Andreas Schwarting; Thomas Orth; K H Meyer zum Büschenfelde
[Anti-endothelial cell antibodies].
Deutsche medizinische Wochenschrift (1946) 1996;121(21):702-9.
1996: Werner-Johannes Mayet; Andreas Schwarting; Thomas Orth; Rainer Duchmann; K H Meyer zum Büschenfelde
Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1).
Clinical and experimental immunology 1996;103(2):259-67.
1996: Andreas Schwarting; Joerg F Schlaak; Johannes Lotz; I Pfers; K H Meyer zum Büschenfelde; Werner-Johannes Mayet
Endothelin-1 modulates the expression of adhesion molecules on fibroblast-like synovial cells (FLS).
Scandinavian journal of rheumatology 1996;25(4):246-56.
1995: Joerg F Schlaak; Andreas Schwarting; Percy A Knolle; K H Meyer zum Büschenfelde; Werner-Johannes Mayet
Effects of Th1 and Th2 cytokines on cytokine production and ICAM-1 expression on synovial fibroblasts.
Annals of the rheumatic diseases 1995;54(7):560-5.
1995: Rainer Duchmann; Andreas Schwarting; T Poralla; K H Meyer zum Büschenfelde; E Hermann
Thymoma and pure red cell aplasia in a patient with systemic lupus erythematosus.
Scandinavian journal of rheumatology 1995;24(4):251-4.
1994: Werner-Johannes Mayet; Andreas Schwarting; K H Meyer zum Büschenfelde
Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells.
Clinical and experimental immunology 1994;97(3):458-65.
1994: W Herr; Andreas Schwarting; B Wittig; Roland Wanitschke; G Schnitzler; J Weinerth; W Jochum; Ulrich Hake; K H Meyer zum Büschenfelde
Enormous hemangiosarcoma of the heart.
The Clinical investigator 1994;72(5):372-6.